Tower Research Capital (TRC)’s Enact Holdings ACT Stock Holding History
Bought
Maintained
Sold
Other funds holding ACT
GCM
Tower Research Capital (TRC)'s ACT Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its Enact Holdings (ACT) stake by 15% in Q2 2026, buying an estimated $11.6K and bringing the position to 2,103 shares worth $96.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2213.
Tower Research Capital (TRC) first reported a position in ACT in Q3 2021 and has held it in 20 quarters since. The position peaked at $560K in Q2 2024. 251 funds tracked by Wall St. Rank hold ACT as of Q2 2026.
- Tower Research Capital (TRC) held 2,103 shares of Enact Holdings worth $96.1K as of Q2 2026.
- Tower Research Capital (TRC) bought 272 Enact Holdings shares in Q2 2026, an estimated $11.6K.
- Enact Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2213 holding.
- Tower Research Capital (TRC) first reported a position in Enact Holdings in Q3 2021 and has held it in 20 quarters since.
- Tower Research Capital (TRC)'s Enact Holdings position peaked at $560K in Q2 2024.
- 251 funds tracked by Wall St. Rank held Enact Holdings as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.